Analysts tweak 12-month target prices on Fisher & Paykel Healthcare

Analysts tweak 12-month target prices on Fisher & Paykel Healthcare
(Image: Fisher & Paykel Healthcare)
Rebecca Howard
Analysts rejigged their 12-month target prices on Fisher & Paykel Healthcare after it lifted its full-year guidance but retained fairly downbeat ratings. Last Friday, the healthcare products manufacturer lifted its full-year revenue guidance to $1.73 billion, from $1.7b, and net profit to $260 million-$265m, from $250m-$260m.Forsyth Barr analysts lifted their target price to $23.45 from $22.95. The shares last traded at $26.62.They noted that F&P Healthcare referenced stronger hospital consumables revenue and “homecare r...

More Markets

NZ sharemarket rocked by US inflation data
Markets Market close

NZ sharemarket rocked by US inflation data

The S&P/NZX 50 Index closed at 141.34 points or 1.18%.

Duncan Bridgeman 26 Apr 2024
Australian company seeks A$30m for Otago gold mining
Markets

Australian company seeks A$30m for Otago gold mining

Santana Minerals wants to 'rapidly advance' a South Island gold mining project.

John Anthony 26 Apr 2024
NZ sharemarket celebrates highest single-day rise in over five months
Markets Market close

NZ sharemarket celebrates highest single-day rise in over five months

The S&P/NZX 50 Index closed at 11,946.43, increasing 143.15 points or 1.21%.

Graham Skellern 24 Apr 2024
'Serious compliance breaches' in NZ sharemarket
Markets

'Serious compliance breaches' in NZ sharemarket

Seven matters were referred to the NZ Markets Disciplinary Tribunal last year.

Murray Jones 24 Apr 2024